WFSBP 2019 Final Program

SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd. Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. © 2019 Sunovion Pharmaceuticals Inc. All rights reserved. Please join us for two special Satellite Symposia of WFSBP 2019, with educational and financial support provided by Sunovion Pharmaceuticals and Sumitomo Dainippon Pharma Q&A will follow each symposium Wednesday, June 5, 2019 | 13:15–14:45 Vancouver Convention Centre East East Meeting Room 8/15 Targeting Recovery in Schizophrenia: The Role of Early Intervention, Digital Health, and Multiple Symptom Domains Professor John M. Kane Dr. Kazuyuki Nakagome Introduction: NewDirections in the Treatment of Early Phase Schizophrenia: The Importance of Resilience, Recovery, and the Use of Technology New Multimodal Therapeutic Approach to Realize Recovery in Patients With Schizophrenia Professor Christoph U. Correll Going Beyond Positive Symptoms to Improve Outcomes in Schizophrenia Professor Roger McIntyre Professor Manpreet Singh Introduction: Pediatric and Adult Bipolar Depression: Diagnostic Challenges and Treatment Approaches Professor Roger McIntyre Bipolar Depression in Adults Pediatric Bipolar Depression Monday, June 3, 2019 | 13:15–14:45 Vancouver Convention Centre East East Meeting Room 8/15 Pediatric and Adult Bipolar Depression: Diagnostic Challenges and Treatment Approaches